Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Hirenallur-Shanthappa D"'
Autor:
Shi Y; Internal Medicine Research Unit Cambridge MA.; Pfizer Inc. Cambridge MA., Perez-Bonilla P; Global Discovery, Investigative & Translational Sciences - Animal Models & Imaging Cambridge MA.; Pfizer Inc. Cambridge MA., Chen X; Global Discovery, Investigative & Translational Sciences - Animal Models & Imaging Cambridge MA.; Pfizer Inc. Cambridge MA., Tam K; Internal Medicine Research Unit Cambridge MA.; Pfizer Inc. Cambridge MA., Marshall M; Internal Medicine Research Unit Cambridge MA.; Pfizer Inc. Cambridge MA., Morin J; Global Discovery, Investigative & Translational Sciences - Animal Models & Imaging Cambridge MA.; Pfizer Inc. Cambridge MA., LaViolette B; Global Discovery, Investigative & Translational Sciences - Animal Models & Imaging Cambridge MA.; Pfizer Inc. Cambridge MA., Kue NR; Internal Medicine Research Unit Cambridge MA.; Pfizer Inc. Cambridge MA., Damilano F; Internal Medicine Research Unit Cambridge MA.; Pfizer Inc. Cambridge MA., Miller RA; Internal Medicine Research Unit Cambridge MA.; Pfizer Inc. Cambridge MA., Zhang BB; Internal Medicine Research Unit Cambridge MA.; Pfizer Inc. Cambridge MA., Roth Flach RJ; Internal Medicine Research Unit Cambridge MA.; Pfizer Inc. Cambridge MA., Hirenallur-Shanthappa D; Global Discovery, Investigative & Translational Sciences - Animal Models & Imaging Cambridge MA.; Pfizer Inc. Cambridge MA.
Publikováno v:
Journal of the American Heart Association [J Am Heart Assoc] 2024 Nov 22, pp. e035894. Date of Electronic Publication: 2024 Nov 22.
Autor:
Filipski KJ; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Martinez-Alsina LA; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Reese MR; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Evrard E; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Buzon LM; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Cameron KO; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Zhang Y; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Coffman KJ; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Bradow J; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Kormos BL; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Liu S; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Knafels JD; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Sahasrabudhe PV; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Chen J; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Kalgutkar AS; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Bessire AJ; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Orozco CC; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Balesano A; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Cerny MA; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Bollinger E; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Reyes AR; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Laforest B; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Rosado A; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Williams G; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Marshall M; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Tam Neale K; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Chen X; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Hirenallur-Shanthappa D; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Stansfield JC; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Groarke J; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Qiu R; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Karas S; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Roth Flach RJ; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Esler WP; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2024 Nov 19. Date of Electronic Publication: 2024 Nov 19.
Autor:
Crane JD; Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts, USA. Electronic address: Justin.Crane@pfizer.com., Barrandon O; Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts, USA., Faherty B; Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts, USA., Gorgoglione M; Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts, USA., Crowley C; Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts, USA., Morin J; Global Discovery Investigative and Translational Sciences CM-DSRD, Pfizer Inc, Cambridge, Massachusetts, USA., Ross TT; Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts, USA., Shimkonis J; Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts, USA., Li D; Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts, USA., Hirenallur-Shanthappa D; Global Discovery Investigative and Translational Sciences CM-DSRD, Pfizer Inc, Cambridge, Massachusetts, USA., Boucher M; Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts, USA., Ahn Y; Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts, USA., Clasquin MF; Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts, USA.
Publikováno v:
Journal of lipid research [J Lipid Res] 2024 Oct; Vol. 65 (10), pp. 100634. Date of Electronic Publication: 2024 Aug 24.
Autor:
Perez-Bonilla P; Global Discovery, Investigative & Translational Sciences-Animal Models and Imaging, Pfizer Inc, Cambridge, Massachusetts, United States of America., LaViolette B; Global Discovery, Investigative & Translational Sciences-Animal Models and Imaging, Pfizer Inc, Cambridge, Massachusetts, United States of America., Bhandary B; Rare Diseases Research Unit, Pfizer Inc, Cambridge, Massachusetts, United States of America., Ullas S; Global Discovery, Investigative & Translational Sciences-Animal Models and Imaging, Pfizer Inc, Cambridge, Massachusetts, United States of America., Chen X; Global Discovery, Investigative & Translational Sciences-Animal Models and Imaging, Pfizer Inc, Cambridge, Massachusetts, United States of America., Hirenallur-Shanthappa D; Global Discovery, Investigative & Translational Sciences-Animal Models and Imaging, Pfizer Inc, Cambridge, Massachusetts, United States of America.
Publikováno v:
PloS one [PLoS One] 2024 Jul 22; Vol. 19 (7), pp. e0307467. Date of Electronic Publication: 2024 Jul 22 (Print Publication: 2024).
Autor:
Perfitt TL; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Huichalaf C; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Gooch R; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Kuperman A; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Ahn Y; Target Sciences, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Chen X; Comparative Medicine, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Ullas S; Comparative Medicine, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Hirenallur-Shanthappa D; Comparative Medicine, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Zhan Y; Drug Safety Research and Development, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Otis D; Drug Safety Research and Development, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Whiteley LO; Drug Safety Research and Development, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Bulawa C; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Martelli A; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States.
Publikováno v:
American journal of physiology. Heart and circulatory physiology [Am J Physiol Heart Circ Physiol] 2024 Feb 01; Vol. 326 (2), pp. H357-H369. Date of Electronic Publication: 2023 Dec 01.
Autor:
Smith KR; WRDM Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts., Wang W; WRDM Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts., Miller MR; WRDM Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts., Boucher M; WRDM Drug Safety, Research and Development, Pfizer Inc, Groton, Connecticut., Reynold JE; WRDM Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts., Daurio NA; WRDM Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts., Li D; WRDM Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts., Hirenallur-Shanthappa D; WRDM Comparative Medicine, Pfizer Inc, Cambridge, Massachusetts., Ahn Y; WRDM Target Sciences, Pfizer Inc, Cambridge, Massachusetts., Beebe DA; WRDM Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts., Kelly KL; WRDM Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts., Ross TT; WRDM Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts., Bence KK; WRDM Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts., Wan M; WRDM Internal Medicine Research Unit, Pfizer Inc, Cambridge, Massachusetts. Electronic address: Min.Wan@pfizer.com.
Publikováno v:
Cellular and molecular gastroenterology and hepatology [Cell Mol Gastroenterol Hepatol] 2024; Vol. 17 (2), pp. 279-291. Date of Electronic Publication: 2023 Oct 14.
Autor:
McElhanon KE; Rare Disease Research Unit, Worldwide Research, Development, and Medical, Pfizer, Inc., Cambridge, MA, USA., Huff TC; Rare Disease Research Unit, Worldwide Research, Development, and Medical, Pfizer, Inc., Cambridge, MA, USA., Hirenallur-Shanthappa D; Comparative Medicine, Worldwide Research, Development, and Medical, Pfizer, Inc., Cambridge, MA, USA. DineshH@pfizer.com., Miller RA; Rare Disease Research Unit, Worldwide Research, Development, and Medical, Pfizer, Inc., Cambridge, MA, USA., Christoforou N; Rare Disease Research Unit, Worldwide Research, Development, and Medical, Pfizer, Inc., Cambridge, MA, USA. nchristoforou@gmail.com.
Publikováno v:
Scientific reports [Sci Rep] 2023 Dec 06; Vol. 13 (1), pp. 21541. Date of Electronic Publication: 2023 Dec 06.
Autor:
Duan C; Early Clinical Development, Pfizer Incorporated, Cambridge, Massachusetts., Montgomery MK; Comparative Medicine, Pfizer Incorporated, Cambridge, Massachusetts., Chen X; Comparative Medicine, Pfizer Incorporated, Cambridge, Massachusetts., Ullas S; Comparative Medicine, Pfizer Incorporated, Cambridge, Massachusetts., Stansfield J; Early Clinical Development, Pfizer Incorporated, Cambridge, Massachusetts., McElhanon K; Rare Disease Research Unit, Pfizer Incorporated, Cambridge, Massachusetts., Hirenallur-Shanthappa D; Comparative Medicine, Pfizer Incorporated, Cambridge, Massachusetts.
Publikováno v:
American journal of physiology. Heart and circulatory physiology [Am J Physiol Heart Circ Physiol] 2022 Oct 01; Vol. 323 (4), pp. H628-H639. Date of Electronic Publication: 2022 Aug 19.
Autor:
Albuquerque B; Internal Medicine Research Unit, Pfizer Worldwide Research, Development & Medical, Cambridge, MA 02139, USA., Chen X; Comparative Medicine, Pfizer Worldwide Research, Development & Medical, Cambridge, MA 02139, USA., Hirenallur-Shanthappa D; Comparative Medicine, Pfizer Worldwide Research, Development & Medical, Cambridge, MA 02139, USA., Zhao Y; Internal Medicine Research Unit, Pfizer Worldwide Research, Development & Medical, Cambridge, MA 02139, USA., Stansfield JC; Biostatistics, Early Clinical Development, Pfizer Worldwide Research, Development & Medical, Cambridge, MA 02139, USA., Zhang BB; Internal Medicine Research Unit, Pfizer Worldwide Research, Development & Medical, Cambridge, MA 02139, USA., Sheikh A; Internal Medicine Research Unit, Pfizer Worldwide Research, Development & Medical, Cambridge, MA 02139, USA., Wu Z; Internal Medicine Research Unit, Pfizer Worldwide Research, Development & Medical, Cambridge, MA 02139, USA.
Publikováno v:
Cells [Cells] 2022 Mar 23; Vol. 11 (7). Date of Electronic Publication: 2022 Mar 23.
Autor:
Huichalaf C; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer Inc., 610 Main Street, Cambridge, MA 02139, USA., Perfitt TL; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer Inc., 610 Main Street, Cambridge, MA 02139, USA., Kuperman A; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer Inc., 610 Main Street, Cambridge, MA 02139, USA., Gooch R; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer Inc., 610 Main Street, Cambridge, MA 02139, USA., Kovi RC; Drug Safety Research and Development, Worldwide Research, Development and Medical, Pfizer Inc., Cambridge, MA 02139, USA., Brenneman KA; Drug Safety Research and Development, Worldwide Research, Development and Medical, Pfizer Inc., Cambridge, MA 02139, USA., Chen X; Comparative Medicine, Worldwide Research, Development and Medical, Pfizer Inc., Cambridge, MA 02139, USA., Hirenallur-Shanthappa D; Comparative Medicine, Worldwide Research, Development and Medical, Pfizer Inc., Cambridge, MA 02139, USA., Ma T; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer Inc., 610 Main Street, Cambridge, MA 02139, USA., Assaf BT; Drug Safety Research and Development, Worldwide Research, Development and Medical, Pfizer Inc., Cambridge, MA 02139, USA., Pardo I; Drug Safety Research and Development, Worldwide Research, Development and Medical, Pfizer Inc., Cambridge, MA 02139, USA., Franks T; Drug Safety Research and Development, Worldwide Research, Development and Medical, Pfizer Inc., Cambridge, MA 02139, USA., Monarski L; Drug Safety Research and Development, Worldwide Research, Development and Medical, Pfizer Inc., Cambridge, MA 02139, USA., Cheng TW; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer Inc., 610 Main Street, Cambridge, MA 02139, USA., Le K; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer Inc., 610 Main Street, Cambridge, MA 02139, USA., Su C; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer Inc., 610 Main Street, Cambridge, MA 02139, USA., Somanathan S; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer Inc., 610 Main Street, Cambridge, MA 02139, USA., Whiteley LO; Drug Safety Research and Development, Worldwide Research, Development and Medical, Pfizer Inc., Cambridge, MA 02139, USA., Bulawa C; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer Inc., 610 Main Street, Cambridge, MA 02139, USA., Pregel MJ; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer Inc., 610 Main Street, Cambridge, MA 02139, USA., Martelli A; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer Inc., 610 Main Street, Cambridge, MA 02139, USA.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2022 Feb 07; Vol. 24, pp. 367-378. Date of Electronic Publication: 2022 Feb 07 (Print Publication: 2022).